Francine Kaufman has sold SENS and made no open-market buys since Jun 2021

Francine R. Kaufman, M.D. is an American endocrinologist and corporate insider serving as Chief Medical Officer at Senseonics Holdings, Inc., a medical technology company focused on long-term continuous glucose monitoring for people with diabetes.( In that role, she helps drive the clinical value proposition and innovation platform for the Eversense CGM system.( Her recent insider activity at Senseonics consisted of equity compensation awards rather than open-market trading.(

Dr. Kaufman’s career spans nearly four decades in diabetes care, with leadership roles including director of the Comprehensive Childhood Diabetes Center and head of the Center for Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles, as well as Chief Medical Officer and Vice President of Global Clinical, Regulatory and Medical Affairs at Medtronic Diabetes.( She is a Distinguished Professor Emerita of Pediatrics and Communications at the University of Southern California’s Keck School of Medicine and Annenberg School of Communications, served as president of the American Diabetes Association, chaired the National Diabetes Education Program, and was elected to the National Academy of Medicine.( She earned a Bachelor of Arts from Northwestern University and graduated as valedictorian of her class at Chicago Medical School.(

Written by Perplexity from public sources.